
|Articles|March 1, 2003
Your Guide to San Francisco
Local places of interest
Advertisement
Newsletter
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
Next-Generation IL-4Rα Targeting and Potential Dermatologic Implications
2
Off-Label Case Series: Topical Roflumilast for Mild HS
3
Recludix Pharma’s REX-8756 for Type 2 Inflammatory Diseases Enters First Human Trials
4
Comparative Analysis Positions Zasocitinib Among Next-Generation TYK2 Inhibitors
5


















